2024-07-3176132.8 MB423页
2025-05-1376115.93 MB482页
2024-07-3075101.69 MB401页
2024-08-01757.92 MB376页
2025-04-147515.38 MB126页1
The 52nd edition of the leading clinical reference on treatment of infectious diseases and anti-infective drug information, spiral-bound and printed in a larger font (approximately 8pt) for ease of use. Helpful in day-to-day practice and as a component of your organization's antimicrobial stewardship program, The Sanford Guide provides valuable guidance in the age of antibiotic resistance. Popular with physicians, pharmacists, physician assistants, nurse practitioners, and other clinicians. Coverage includes: Clinical syndromes (pathogens, bacterial, fungal, mycobacterial, parasitic viral), Anti-infective agents (dosing, pediatric adjustments, renal adjustments, adverse effects, activity, pharmacology, drug-drug interactions), Preventative therapy. What's new in 2022: Numerous changes throughout, with major changes in the following areas: New Drugs - Addition of new COVID-19 drugs, cefiderocol, ibrexafungerp, brincidofovir, cabotegravir, doravirine, and more. New Tables - ECMO Drug Dos 2025-04-177532.87 MB324页
2024-07-317459.97 MB2078页
2024-09-06741.52 MB56页
2025-05-107491.13 MB376页1
2025-08-317486 MB1534页
2024-07-317369.71 MB223页
2024-07-3173425.24 MB1052页
2024-08-26739.96 MB396页
2024-07-267238.89 MB638页
2024-12-057259.28 MB143页
本书系统科学地阐述了:根据国家疾病负担的状况如何确立研究课题,选定研究的重点,进行科学的设计,抉择最佳与可行的研究设计方案,定量地选择合格研究对象,确立最佳的试验与对照性干预措施,选定科学测量的终点指标及其合理的统计分析方法等,制订防止偏倚因素干扰的系列方法,以确保研究的真实性和可靠性.再结合临床病因,诊断,治疗,预后,生存质量,临床经济以及临床决策等研究实际,在如何进行具体科学设计与评价方面,更予以深入地阐述,有利于读者联系实际,以指导自己的临床科研与医疗实践 2025-07-297254.07 MB607页6
2024-07-317112.18 MB409页
2025-05-1071186.12 MB689页6
2025-04-167168.16 MB447页
2025-05-137117.69 MB450页
